BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil. 2006;18:6-17. [PMID: 16371078 DOI: 10.1111/j.1365-2982.2005.00685.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Wang CC, Wu H, Lin FH, Gong R, Xie F, Peng Y, Feng J, Hu CH. Sodium butyrate enhances intestinal integrity, inhibits mast cell activation, inflammatory mediator production and JNK signaling pathway in weaned pigs. Innate Immun. 2018;24:40-46. [PMID: 29183244 DOI: 10.1177/1753425917741970] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
2 Lu L, Yan L, Yuan J, Ye Q, Lin J. Shuganyin decoction improves the intestinal barrier function in a rat model of irritable bowel syndrome induced by water-avoidance stress. Chin Med 2018;13:6. [PMID: 29434653 DOI: 10.1186/s13020-017-0161-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Mucosal immune activation in irritable bowel syndrome: Gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392-400. [PMID: 19174797 DOI: 10.1038/ajg.2008.94] [Cited by in Crossref: 222] [Cited by in F6Publishing: 217] [Article Influence: 18.5] [Reference Citation Analysis]
4 Chen ZH, Xiao L, Chen JH, Luo HS, Wang GH, Huang YL, Wang XP. Effects of fluoxetine on mast cell morphology and protease-1 expression in gastric antrum in a rat model of depression. World J Gastroenterol 2008;14:6993-8. [PMID: 19058337 DOI: 10.3748/wjg.14.6993] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Stanghellini V, Barbara G, Cogliandro R, Salvioli B, Cremon C, De Giorgio R, Corinaldesi R. Overlap Between GERD and IBS: Irrefutable But Subtle. Journal of Clinical Gastroenterology 2007;41:S114-7. [DOI: 10.1097/mcg.0b013e31803d0f94] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Chatterjea D, Martinov T. Mast cells: versatile gatekeepers of pain. Mol Immunol 2015;63:38-44. [PMID: 24666768 DOI: 10.1016/j.molimm.2014.03.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
7 Singh UR, Malhotra A, Bhatia A. Eosinophils, mast cells, nerves and ganglion cells in appendicitis. Indian J Surg 2008;70:231-4. [PMID: 23133069 DOI: 10.1007/s12262-008-0066-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
8 Farmer AD, Aziz Q, Tack J, Van Oudenhove L. The future of neuroscientific research in functional gastrointestinal disorders: integration towards multidimensional (visceral) pain endophenotypes? J Psychosom Res 2010;68:475-81. [PMID: 20403507 DOI: 10.1016/j.jpsychores.2009.12.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
9 Friesen CA, Lin Z, Singh M, Singh V, Schurman JV, Burchell N, Cocjin JT, McCallum RW. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci. 2008;53:2634-2640. [PMID: 18320315 DOI: 10.1007/s10620-008-0207-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
10 Wan J, Zhang J, Xu Q, Yin H, Chen D, Yu B, He J. Alginate oligosaccharide protects against enterotoxigenic Escherichia coli-induced porcine intestinal barrier injury. Carbohydr Polym 2021;270:118316. [PMID: 34364589 DOI: 10.1016/j.carbpol.2021.118316] [Reference Citation Analysis]
11 Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol 2016;9:354-75. [PMID: 27134665 DOI: 10.1177/1756283X16633050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
12 Shen B, Liu W, Remzi FH, Shao Z, Lu H, DeLaMotte C, Hammel J, Queener E, Bambrick ML, Fazio VW. Enterochromaffin cell hyperplasia in irritable pouch syndrome. Am J Gastroenterol. 2008;103:2293-2300. [PMID: 18702649 DOI: 10.1111/j.1572-0241.2008.01990.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
13 Homann J, Kolck UW, Ehnes A, Frieling T, Raithel M, Molderings GJ. [Systemic mastocytosis--definition of an internal disease]. Med Klin (Munich) 2010;105:544-53. [PMID: 20824412 DOI: 10.1007/s00063-010-1093-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
14 Tack JF, Miner PB Jr, Fischer L, Harris MS. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;34:868-877. [PMID: 21883322 DOI: 10.1111/j.1365-2036.2011.04818.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
15 De Winter BY, van den Wijngaard RM, de Jonge WJ. Intestinal mast cells in gut inflammation and motility disturbances. Biochim Biophys Acta. 2012;1822:66-73. [PMID: 21497195 DOI: 10.1016/j.bbadis.2011.03.016] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 7.6] [Reference Citation Analysis]
16 Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol 2014;20:14105-25. [PMID: 25339800 DOI: 10.3748/wjg.v20.i39.14105] [Cited by in CrossRef: 175] [Cited by in F6Publishing: 136] [Article Influence: 29.2] [Reference Citation Analysis]
17 Debruin EJ, Gold M, Lo BC, Snyder K, Cait A, Lasic N, Lopez M, Mcnagny KM, Hughes MR. Mast Cells in Human Health and Disease. In: Hughes MR, Mcnagny KM, editors. Mast Cells. New York: Springer; 2015. pp. 93-119. [DOI: 10.1007/978-1-4939-1568-2_7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
18 Gao J, Gillilland MG 3rd, Owyang C. Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship. Gut Microbes 2014;5:571-5. [PMID: 25244596 DOI: 10.4161/gmic.32130] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
19 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.13.6041] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
20 Zhu H, Liu Y, Chen S, Wang X, Pi D, Leng W, Chen F, Zhang J, Kang P. Fish oil enhances intestinal barrier function and inhibits corticotropin-releasing hormone/corticotropin-releasing hormone receptor 1 signalling pathway in weaned pigs after lipopolysaccharide challenge. Br J Nutr 2016;115:1947-57. [PMID: 27080003 DOI: 10.1017/S0007114516001100] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
21 Carotti S, Guarino MP, Cicala M, Perrone G, Alloni R, Segreto F, Rabitti C, Morini S. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients. Neurogastroenterol Motil. 2010;22:866-73, e232. [PMID: 20426797 DOI: 10.1111/j.1365-2982.2010.01510.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
22 Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, De Giorgio R, Bartesaghi G, Canovi B, Barbara G. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther. 2009;30:245-252. [PMID: 19438846 DOI: 10.1111/j.1365-2036.2009.04041.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 7.4] [Reference Citation Analysis]
23 Wattchow D, Heitmann P, Smolilo D, Spencer NJ, Parker D, Hibberd T, Brookes SSJ, Dinning PG, Costa M. Postoperative ileus—An ongoing conundrum. Neurogastroenterology & Motility 2021;33. [DOI: 10.1111/nmo.14046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Rychter JW, Van Nassauw L, Timmermans JP, Akkermans LM, Westerink RH, Kroese AB. CGRP1 receptor activation induces piecemeal release of protease-1 from mouse bone marrow-derived mucosal mast cells. Neurogastroenterol Motil 2011;23:e57-68. [PMID: 20964790 DOI: 10.1111/j.1365-2982.2010.01617.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
25 Friesen CA, Neilan NA, Schurman JV, Taylor DL, Kearns GL, Abdel-Rahman SM. Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. BMC Gastroenterol. 2009;9:32. [PMID: 19432972 DOI: 10.1186/1471-230x-9-32] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
26 Onori P, Gaudio E, Franchitto A, Alpini G, Francis H. Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes. World J Gastrointest Pathophysiol 2010;1:38-49. [PMID: 21607141 DOI: 10.4291/wjgp.v1.i2.38] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Breunig E, Michel K, Zeller F, Seidl S, Weyhern CW, Schemann M. Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol. 2007;583:731-742. [PMID: 17627982 DOI: 10.1113/jphysiol.2007.139352] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 6.8] [Reference Citation Analysis]
28 Ishida K, Takai S, Murano M, Nishikawa T, Inoue T, Murano N, Inoue N, Jin D, Umegaki E, Higuchi K. Role of chymase-dependent matrix metalloproteinase-9 activation in mice with dextran sodium sulfate-induced colitis. J Pharmacol Exp Ther. 2008;324:422-426. [PMID: 18024785 DOI: 10.1124/jpet.107.131946] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
29 Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26-37. [PMID: 17241857 DOI: 10.1053/j.gastro.2006.11.039] [Cited by in Crossref: 484] [Cited by in F6Publishing: 443] [Article Influence: 34.6] [Reference Citation Analysis]
30 Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008;57:923-929. [PMID: 18252749 DOI: 10.1136/gut.2007.138982] [Cited by in Crossref: 316] [Cited by in F6Publishing: 276] [Article Influence: 24.3] [Reference Citation Analysis]
31 Usai-Satta P, Oppia F, Scarpa M, Giannetti C, Cabras F. Delayed gastric emptying does not normalize after gluten withdrawal in adult celiac disease. Scand J Gastroenterol. 2016;51:923-926. [PMID: 27161492 DOI: 10.3109/00365521.2016.1157893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
32 Zhang S, Grabauskas G, Wu X, Joo MK, Heldsinger A, Song I, Owyang C, Yu S. Role of prostaglandin D2 in mast cell activation-induced sensitization of esophageal vagal afferents. Am J Physiol Gastrointest Liver Physiol 2013;304:G908-16. [PMID: 23471341 DOI: 10.1152/ajpgi.00448.2012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
33 Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007;19:545-552. [PMID: 17593135 DOI: 10.1111/j.1365-2982.2007.00925.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 6.8] [Reference Citation Analysis]
34 Wald A, Rakel D. Behavioral and complementary approaches for the treatment of irritable bowel syndrome. Nutr Clin Pract. 1999;23:284-292. [PMID: 18595861 DOI: 10.1177/0884533608318677] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
35 Raoof R, Willemen HLDM, Eijkelkamp N. Divergent roles of immune cells and their mediators in pain. Rheumatology (Oxford) 2018;57:429-40. [PMID: 28968842 DOI: 10.1093/rheumatology/kex308] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
36 Pigrau M, Rodiño-Janeiro BK, Casado-Bedmar M, Lobo B, Vicario M, Santos J, Alonso-Cotoner C. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome. Neurogastroenterol Motil 2016;28:463-86. [PMID: 26556786 DOI: 10.1111/nmo.12717] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
37 Benini F, Mora A, Turini D, Bertolazzi S, Lanzarotto F, Ricci C, Villanacci V, Barbara G, Stanghellini V, Lanzini A. Slow gallbladder emptying reverts to normal but small intestinal transit of a physiological meal remains slow in celiac patients during gluten-free diet: Intestinal transit in celiacs. Neurogastroenterology & Motility 2012;24:100-e80. [DOI: 10.1111/j.1365-2982.2011.01822.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Russo G, Caliendo G, Santagada V, Cirino G, Wallace JL, Fiorucci S. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J Pharmacol Exp Ther 2006;319:447-58. [PMID: 16855178 DOI: 10.1124/jpet.106.106435] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 6.6] [Reference Citation Analysis]
39 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.v13.45.6041] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
40 Rijnierse A, Nijkamp FP, Kraneveld AD. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther. 2007;116:207-235. [PMID: 17719089 DOI: 10.1016/j.pharmthera.2007.06.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
41 Meloto CB, Ingelmo P, Perez EV, Pitt R, González Cárdenas VH, Mohamed N, Sotocinal SG, Bourassa V, Lima LV, Ribeiro-da-Silva A, Mogil JS, Diatchenko L. Mast cell stabilizer ketotifen fumarate reverses inflammatory but not neuropathic-induced mechanical pain in mice. Pain Rep 2021;6:e902. [PMID: 34104835 DOI: 10.1097/PR9.0000000000000902] [Reference Citation Analysis]
42 Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha PJ. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology. 2007;132:615-627. [PMID: 17258716 DOI: 10.1053/j.gastro.2006.11.014] [Cited by in Crossref: 158] [Cited by in F6Publishing: 147] [Article Influence: 10.5] [Reference Citation Analysis]
43 Zare-Mirzaie A, Lotfi M, Sadeghipour A, Haghi-Ashtiani MT. Analysis of colonic mucosa mast cell count in patients with chronic diarrhea. Saudi J Gastroenterol. 2012;18:322-326. [PMID: 23006460 DOI: 10.4103/1319-3767.101128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
44 Mulak A, Taché Y, Larauche M. Sex hormones in the modulation of irritable bowel syndrome. World J Gastroenterol. 2014;20:2433-2448. [PMID: 24627581 DOI: 10.3748/wjg.v20.i10.2433] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 92] [Article Influence: 17.7] [Reference Citation Analysis]
45 de Lima MB, Gama LA, Hauschildt AT, Dall'Agnol DJR, Corá LA, Americo MF. Gastrointestinal Motility, Mucosal Mast Cell, and Intestinal Histology in Rats: Effect of Prednisone. Biomed Res Int 2017;2017:4637621. [PMID: 29057260 DOI: 10.1155/2017/4637621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
46 Van Op den bosch J, Van Nassauw L, Van Marck E, Timmermans JP. Somatostatin modulates mast cell-induced responses in murine spinal neurons and satellite cells. Am J Physiol Gastrointest Liver Physiol 2009;297:G406-17. [PMID: 19477916 DOI: 10.1152/ajpgi.00059.2009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
47 Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol. 2009;16:540-550. [PMID: 19835795 DOI: 10.1016/j.jmig.2009.06.017] [Cited by in Crossref: 124] [Cited by in F6Publishing: 90] [Article Influence: 10.3] [Reference Citation Analysis]
48 Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Antonelli E, Fanini L, Salerni B. Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia. Dig Dis Sci. 2012;57:65-71. [PMID: 21814802 DOI: 10.1007/s10620-011-1848-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
49 Deiteren A, De Man JG, Pelckmans PA, De Winter BY. Histamine H₄ receptors in the gastrointestinal tract. Br J Pharmacol 2015;172:1165-78. [PMID: 25363289 DOI: 10.1111/bph.12989] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
50 Saad AG. Normal Quantity and Distribution of Mast Cells and Eosinophils in the Pediatric Colon. Pediatr Dev Pathol 2011;14:294-300. [DOI: 10.2350/10-07-0878-oa.1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
51 De Lisle RC, Meldi L, Roach E, Flynn M, Sewell R. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse. PLoS One 2009;4:e4283. [PMID: 19172182 DOI: 10.1371/journal.pone.0004283] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
52 Van Nassauw L, Adriaensen D, Timmermans JP. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton Neurosci. 2007;133:91-103. [PMID: 17169619 DOI: 10.1016/j.autneu.2006.10.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
53 Zhang L, Song J, Hou X. Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside. J Neurogastroenterol Motil. 2016;22:181-192. [PMID: 26755686 DOI: 10.5056/jnm15137] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 13.0] [Reference Citation Analysis]
54 Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Sabatino G, Maurer CA, Cathomas G, Salerni B. Colonic mast cells in controls and slow transit constipation patients. Aliment Pharmacol Ther. 2011;34:92-99. [PMID: 21539589 DOI: 10.1111/j.1365-2036.2011.04684.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
55 Chun E, Yoon S, Parveen A, Jin M. Alleviation of Irritable Bowel Syndrome-Like Symptoms and Control of Gut and Brain Responses with Oral Administration of Dolichos lablab L. in a Mouse Model. Nutrients 2018;10:E1475. [PMID: 30309025 DOI: 10.3390/nu10101475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
56 Liu D, Gan X, Huang P, Chen X, Ge M, Hei Z. Inhibiting tryptase after ischemia limits small intestinal ischemia-reperfusion injury through protease-activated receptor 2 in rats. Journal of Trauma and Acute Care Surgery 2012;73:1138-44. [DOI: 10.1097/ta.0b013e318265d08d] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
57 Akhavein M A, Patel NR, Muniyappa PK, Glover SC. Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterol Res Pract 2012;2012:950582. [PMID: 22577375 DOI: 10.1155/2012/950582] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
58 Young P, Cash BD. Probiotic use in irritable bowel syndrome. Curr Gastroenterol Rep 2006;8:321-6. [DOI: 10.1007/s11894-006-0053-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
59 Park SW, Lee H, Lee HJ, Chung H, Park JC, Shin SK, Lee SK, Lee YC. Esophageal mucosal mast cell infiltration and changes in segmental smooth muscle contraction in noncardiac chest pain. Dis Esophagus 2015;28:512-9. [PMID: 24766344 DOI: 10.1111/dote.12231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
60 Park BK, Chun E, Choi JJ, Shin Y, Kho YT, Oh SH, Kim SY, Lee TH, Kim TW, Shin E, Do SG, Jin M. Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model. J Med Food 2017;20:474-84. [PMID: 28452565 DOI: 10.1089/jmf.2016.3844] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
61 De Winter BY, De Man JG. Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility. World J Gastroenterol. 2010;16:5523-5535. [PMID: 21105185 DOI: 10.3748/wjg.v16.i44.5523] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
62 Park KS, Ahn SH, Hwang JS, Cho KB, Chung WJ, Jang BK, Kang YN, Kwon JH, Kim YH. A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients. Dig Dis Sci. 2008;53:704-711. [PMID: 17717743 DOI: 10.1007/s10620-007-9930-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
63 Buhner S, Schemann M. Mast cell–nerve axis with a focus on the human gut. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012;1822:85-92. [DOI: 10.1016/j.bbadis.2011.06.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 9.2] [Reference Citation Analysis]
64 Ji Y, Hu B, Klontz C, Li J, Dessem D, Dorsey SG, Traub RJ. Peripheral mechanisms contribute to comorbid visceral hypersensitivity induced by preexisting orofacial pain and stress in female rats. Neurogastroenterol Motil 2020;32:e13833. [PMID: 32155308 DOI: 10.1111/nmo.13833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Cremon C, Pallotti F, Bacchilega M, Stanghellini V, Corinaldesi R, Barbara G. Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:735-740. [PMID: 19090734 DOI: 10.1586/17474124.2.6.735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
66 Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci. 2008;53:1246-1251. [PMID: 17932763 DOI: 10.1007/s10620-007-0022-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
67 Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 2011;128:147-152.e2. [PMID: 21621255 DOI: 10.1016/j.jaci.2011.04.037] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
68 Manning J, Buckley MM, O'Halloran KD, O'Malley D. In vivo neutralization of IL-6 receptors ameliorates gastrointestinal dysfunction in dystrophin-deficient mdx mice. Neurogastroenterol Motil 2016;28:1016-26. [PMID: 26920808 DOI: 10.1111/nmo.12803] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
69 Sand E, Themner-Persson A, Ekblad E. Infiltration of mast cells in rat colon is a consequence of ischemia/reperfusion. Dig Dis Sci 2008;53:3158-69. [PMID: 18463982 DOI: 10.1007/s10620-008-0279-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
70 Vanheel H, Vicario M, Beeckmans D, Cocca S, Wauters L, Accarie A, Toth J, Rodewald HR, De Hertogh G, Matteoli G, Boeckxstaens G, Tack J, Farre R, Vanuytsel T. Duodenal acidification induces gastric relaxation and alters epithelial barrier function by a mast cell independent mechanism. Sci Rep 2020;10:17448. [PMID: 33060783 DOI: 10.1038/s41598-020-74491-1] [Reference Citation Analysis]
71 Barbara G. Mucosal barrier defects in irritable bowel syndrome. Who left the door open? Am J Gastroenterol. 2006;101:1295-1298. [PMID: 16771952 DOI: 10.1111/j.1572-0241.2006.00667.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
72 Vermeulen W, De Man JG, Pelckmans PA, De Winter BY. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol. 2014;20:1005-1020. [PMID: 24574773 DOI: 10.3748/wjg.v20.i4.1005] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
73 Zhao JM, Chen L, Zhou CL, Shi Y, Li YW, Shang HX, Wu LY, Bao CH, Dou CZ, Wu HG. Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome. Evid Based Complement Alternat Med 2016;2016:9410505. [PMID: 27738447 DOI: 10.1155/2016/9410505] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
74 Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil 2010;16:363-73. [PMID: 21103418 DOI: 10.5056/jnm.2010.16.4.363] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
75 Kayssi A, Amadesi S, Bautista F, Bunnett NW, Vanner S. Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon. J Physiol. 2007;580:977-991. [PMID: 17289784 DOI: 10.1113/jphysiol.2006.126599] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
76 Hillsley K, Lin JH, Stanisz A, Grundy D, Aerssens J, Peeters PJ, Moechars D, Coulie B, Stead RH. Dissecting the role of sodium currents in visceral sensory neurons in a model of chronic hyperexcitability using Nav1.8 and Nav1.9 null mice. J Physiol 2006;576:257-67. [PMID: 16857712 DOI: 10.1113/jphysiol.2006.113597] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
77 Bonamichi-santos R, Castells M. Mast Cell Activation Syndromes. Curr Treat Options Allergy 2016;3:384-400. [DOI: 10.1007/s40521-016-0100-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
78 van den wijngaard RM, klooker TK, welting O, stanisor OI, wouters MM, van der coelen D, bulmer DC, peeters PJ, aerssens J, de hoogt R, lee K, de jonge WJ, boeckxstaens GE. Essential role for TRPV1 in stress-induced (mast cell-dependent) colonic hypersensitivity in maternally separated rats. Neurogastroenterology & Motility 2009;21:1107-e94. [DOI: 10.1111/j.1365-2982.2009.01339.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 7.0] [Reference Citation Analysis]
79 Hattay P, Prusator DK, Tran L, Greenwood-van Meerveld B. Psychological stress-induced colonic barrier dysfunction: Role of immune-mediated mechanisms. Neurogastroenterol Motil 2017;29:e13043. [DOI: 10.1111/nmo.13043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
80 Usai-Satta P, Oppia F, Lai M, Cabras F. Motility Disorders in Celiac Disease and Non-Celiac Gluten Sensitivity: The Impact of a Gluten-Free Diet. Nutrients 2018;10:E1705. [PMID: 30405092 DOI: 10.3390/nu10111705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Penissi AB, Vera ME, Mariani ML, Rudolph MI, Ceñal JP, de Rosas JC, Fogal TH, Tonn CE, Favier LS, Giordano OS, Piezzi RS. Novel anti-ulcer α,β-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation. European Journal of Pharmacology 2009;612:122-30. [DOI: 10.1016/j.ejphar.2009.03.052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
82 Borrelli O, Barbara G, Di Nardo G, Cremon C, Lucarelli S, Frediani T, Paganelli M, De Giorgio R, Stanghellini V, Cucchiara S. Neuroimmune Interaction and Anorectal Motility in Children With Food Allergy-Related Chronic Constipation. Am J Gastroenterol 2009;104:454-63. [DOI: 10.1038/ajg.2008.109] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
83 Yu Y, Ding X, Wang Q, Xie L, Hu W, Chen K. Alterations of Mast Cells in the Esophageal Mucosa of the Patients With Non-Erosive Reflux Disease. Gastroenterology Res 2011;4:70-5. [PMID: 27942317 DOI: 10.4021/gr284w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
84 Yeom JS, Choi MB, Seo JH, Park JS, Lim JY, Park CH, Woo HO, Youn HS, Ko GH, Baik SC. Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia. Cephalalgia. 2013;33:323-329. [PMID: 23291287 DOI: 10.1177/0333102412472070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
85 Yen EF, Pardi DS. Review article: Microscopic colitis--lymphocytic, collagenous and ‘mast cell’ colitis. Aliment Pharmacol Ther. 2011;34:21-32. [PMID: 21545473 DOI: 10.1111/j.1365-2036.2011.04686.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
86 Moeser AJ, Ryan KA, Nighot PK, Blikslager AT. Gastrointestinal dysfunction induced by early weaning is attenuated by delayed weaning and mast cell blockade in pigs. Am J Physiol Gastrointest Liver Physiol 2007;293:G413-21. [PMID: 17525151 DOI: 10.1152/ajpgi.00304.2006] [Cited by in Crossref: 127] [Cited by in F6Publishing: 108] [Article Influence: 9.1] [Reference Citation Analysis]
87 Balestra B, Vicini R, Cremon C, Zecchi L, Dothel G, Vasina V, De Giorgio R, Paccapelo A, Pastoris O, Stanghellini V. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Neurogastroenterol Motil. 2012;24:e1118-e1570. [PMID: 22937879 DOI: 10.1111/nmo.12000] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
88 Afrin LB, Pöhlau D, Raithel M, Haenisch B, Dumoulin FL, Homann J, Mauer UM, Harzer S, Molderings GJ. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain, Behavior, and Immunity 2015;50:314-21. [DOI: 10.1016/j.bbi.2015.07.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
89 Casselbrant A, Kostic S, Lönroth H. The muscular expression of RAS in patients with achalasia. J Renin Angiotensin Aldosterone Syst 2015;16:578-86. [PMID: 24468662 DOI: 10.1177/1470320313498294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
90 Barbara G, Cremon C, De Giorgio R, Dothel G, Zecchi L, Bellacosa L, Carini G, Stanghellini V, Corinaldesi R. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315. [PMID: 21537962 DOI: 10.1007/s11894-011-0195-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 6.9] [Reference Citation Analysis]
91 Albert-Bayo M, Paracuellos I, González-Castro AM, Rodríguez-Urrutia A, Rodríguez-Lagunas MJ, Alonso-Cotoner C, Santos J, Vicario M. Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis. Cells 2019;8:E135. [PMID: 30744042 DOI: 10.3390/cells8020135] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 26.0] [Reference Citation Analysis]
92 Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28:994-1002. [PMID: 18671775 DOI: 10.1111/j.1365-2036.2008.03818.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 9.3] [Reference Citation Analysis]
93 Chu HQ, Li J, Huang HP, Hao WD, Duan LP, Wei XT. Protective effects of tranilast on oxazolone-induced rat colitis through a mast cell-dependent pathway. Dig Liver Dis 2016;48:162-71. [PMID: 26455295 DOI: 10.1016/j.dld.2015.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
94 Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C. Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 2008;120:233-53. [PMID: 18848843 DOI: 10.1016/j.pharmthera.2008.08.010] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 6.7] [Reference Citation Analysis]
95 Westerveld D, Li J, Glover S. Oesophageal mastocytosis: eosinophilic oesophagitis without eosinophils? BMJ Case Rep 2017;2017:bcr-2017-221276. [PMID: 28851715 DOI: 10.1136/bcr-2017-221276] [Reference Citation Analysis]
96 Plavšić I, Hauser G, Tkalčić M, Pletikosić S, Salkić N. Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers. Gastroenterol Res Pract. 2015;2015:490183. [PMID: 26170833 DOI: 10.1155/2015/490183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
97 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 102] [Article Influence: 11.9] [Reference Citation Analysis]
98 Lee H, Chung H, Park JC, Shin SK, lee SK, Lee YC. Heterogeneity of mucosal mast cell infiltration in subgroups of patients with esophageal chest pain. Neurogastroenterol Motil 2014;26:786-93. [DOI: 10.1111/nmo.12325] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
99 Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203-209. [PMID: 17005763 DOI: 10.1136/gut.2006.100594] [Cited by in Crossref: 255] [Cited by in F6Publishing: 228] [Article Influence: 17.0] [Reference Citation Analysis]
100 Chi Y, Li C, Wu LH, Wang HH. The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 2020;55:762-8. [PMID: 32493087 DOI: 10.1080/00365521.2020.1774925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol 2007;13:3027-30. [PMID: 17589915 DOI: 10.3748/wjg.v13.i22.3027] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
102 D'Auria E, Salvatore S, Pozzi E, Mantegazza C, Sartorio MUA, Pensabene L, Baldassarre ME, Agosti M, Vandenplas Y, Zuccotti G. Cow's Milk Allergy: Immunomodulation by Dietary Intervention. Nutrients 2019;11:E1399. [PMID: 31234330 DOI: 10.3390/nu11061399] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
103 Rahman MM, Afroz S, Arthur S, Sundaram U. Mast Cell Mediated Regulation of Small Intestinal Chloride Malabsorption in SAMP1/YitFc Mouse Model of Spontaneous Chronic Ileitis. Cells 2021;10:697. [PMID: 33801010 DOI: 10.3390/cells10030697] [Reference Citation Analysis]
104 Amiot A, Cazals-hatem D, Joly F, Lavergne-slove A, Peuchmaur M, Bouhnik Y, Bedossa P, Messing B. The Role of Immunohistochemistry in Idiopathic Chronic Intestinal Pseudoobstruction (CIPO): A Case-control Study. American Journal of Surgical Pathology 2009;33:749-58. [DOI: 10.1097/pas.0b013e31819b381a] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
105 Galli G, Carabotti M, Pilozzi E, Lahner E, Annibale B, Conti L. Relationship between Persistent Gastrointestinal Symptoms and Duodenal Histological Findings after Adequate Gluten-Free Diet: A Gray Area of Celiac Disease Management in Adult Patients. Nutrients 2021;13:600. [PMID: 33673062 DOI: 10.3390/nu13020600] [Reference Citation Analysis]